Navigation Links
Rheumatoid Arthritis Treatment Guidelines Updated
Date:6/26/2008

New rules called 'extensive' but not meant to crowd physicians' clinical judgment

THURSDAY, June 26 (HealthDay News) -- New recommendations for the use of disease-modifying anti-rheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis (RA) have been developed by the American College of Rheumatology.

The recommendations on the use of non-biologic and biologic DMARDs in RA address five key areas: indications for use; monitoring for side effects; assessing clinical response; screening for tuberculosis (a risk factor associated with biologic DMARDs); and under certain circumstances (i.e. high disease activity) the roles of cost and patient preference in choosing biologic agents.

The recommendations, published in the June issue of the journal Arthritis Care & Research, also take into account RA disease duration, disease severity, and prognostic features.

"These recommendations were developed for specialist clinicians familiar with assessing RA disease activity and disease severity," project co-leader Dr. Kenneth Saag, professor of medicine and epidemiology at the University of Alabama at Birmingham, said in a prepared statement.

"Applying these recommendations to clinical practice requires individualized patient assessment and clinical decision-making. The recommendations developed are not intended to be used in a 'cookbook' or prescriptive manner or to limit a physician's clinical judgment, but rather to provide guidance based on clinical evidence and expert panel input," Saag said.

The recommendations include:

  • Methotrexate or leflunomide therapy is recommended for most RA patients.
  • Methotrexate plus hydroxychloroquine is endorsed for patients with moderate to high disease activity.
  • The triple DMARD combination of methotrexate plus hydroxychloroquine plus sulfasalazine for patients with poor prognostic features and moderate to high levels
    '/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Rheumatoid Arthritis Drug Boosts Melanoma Incidence
2. Rheumatoid arthritis is a risk factor for cardiovascular disease
3. Novel DNA microarray chip predicts functional impairment and remission in rheumatoid arthritis
4. Early life infections increase the risk of rheumatoid arthritis and juvenile idiopathic arthritis
5. Rheumatoid arthritis factors equal to cardiovascular factors in risk of severe cardiovascular events
6. New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
7. HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity
8. Hand bone mineral density is an effective predictor of mortality in rheumatoid arthritis
9. Biogen Idecs baminercept alfa shows promise in patients with rheumatoid arthritis
10. Golimumab Eases Rheumatoid Arthritis Symptoms
11. Researchers uncover higher prevalence of periodontal disease in rheumatoid arthritis patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... New York (PRWEB) September 19, 2014 ... & Game Building Platform . Earlier this month Appy Pie ... Powerful Tools for the Aspiring App Developer' by Yahoo . ... which allows people to develop beautiful applications within minutes and ... development, With advanced features and support for latest mobile operating ...
(Date:9/19/2014)... HealthDay Reporter THURSDAY, ... escalated the fight against antibiotic-resistant bacteria on Thursday, ordering ... deal with the threat. Obama signed an ... charged with crafting a national action plan for dealing ... treatable bacteria that have become resistant to standard antibiotics ...
(Date:9/19/2014)... 2014 ShopRite has launched its new ... with the 2014-2015 school year. The new program will ... eBoxTops and special donations throughout the year. , Customers ... registering their ShopRite Price Plus Card at shopriteformyschool.com can ... favorite school. By using their Price Plus Club Card ...
(Date:9/19/2014)... September 19, 2014 The Translational ... new ND® Infusion Catheter is being used ... , The study commenced on September 4th, 2014 at ... of the new catheter demonstrated a number of advancements ... stem cells. “We are at the forefront of revolutionizing ...
(Date:9/19/2014)... QueenBeeTickets.com has the largest ticket inventory that online ... set to begin on January 21 of 2015, discount John ... secure website. , Click Here to view the ... , The Plain Spoken Tour has recently been announced, and ... a show coming to their local area. Presales have been ...
Breaking Medicine News(10 mins):Health News:Business Insider Australia Rates Appy Pie as a top App & Game Building Platform 2Health News:Obama Calls for National Plan to Fight Antibiotic Resistance 2Health News:ShopRite to Donate Up to $1 Million to Local Schools 2Health News:First-in-man procedure utilizes a new method of stem cell delivery 2Health News:First-in-man procedure utilizes a new method of stem cell delivery 3Health News:John Mellencamp Plain Spoken Tour Tickets: QueenBeeTickets.com Delights Customers with Discount Tickets for Mellencamp’s 80-City 2015 Concert Tour with Carlene Carter 2
... SEATTLE, June 5 Kagome, one of Japan,s ... natural 100 percent juice,blend have been named one of ... the help of top health experts, Health Magazine put ... the ultimate test,and unveiled a total of 75 true ...
... CHAPEL HILL, N.C., June 5 Benchmarking is not ... all economic climates. This research,excerpt presents a survey analysis ... companies on how companies are using benchmarking in a,difficult ... hot topics companies are,choosing to benchmark, the goals of ...
... brain chemical serotonin influences fat metabolism , , THURSDAY, June ... is a frustrating truism familiar to the diet-conscious choosing ... that weight control isn,t just a matter of what ... nervous system is genetically predisposed to process fat. , ...
... Presented by The Massachusetts School of,Professional Psychology, ... in this state about the ,invisible wounds of ... the stress, depression and post traumatic,stress disorder (PTSD) ... of,domestic violence and suicide. We need to begin ...
... Army Corps of,Engineers, in partnership with federal, state ... partners, will,participate in the first National Get Outdoors ... more than 75 organizations will conduct hundreds of,outdoor ... the country according to event co-sponsors, the U.S. ...
... of free health information, giveaways, entertainment and ... ... bodybuilder Chad,Gregory, along with professional fitness and figure competitors Allison,Frahn and Tina ... weekend at the Cobb Galleria Centre in Atlanta., Chad, part of ...
Cached Medicine News:Health News:Kagome's Yellow Mango Orchard Blended Juice Named One of America's Healthiest Buys 2Health News:Kagome's Yellow Mango Orchard Blended Juice Named One of America's Healthiest Buys 3Health News:Demonstrating the Value of Benchmarking in an Uncertain Economy 2Health News:Weight Gain May Not Be Based Just on What You Eat 2Health News:Weight Gain May Not Be Based Just on What You Eat 3Health News:Growing Public Health Crisis of Domestic Violence and Suicides by Returning Veterans 2Health News:Army Corps of Engineers Will Host National Get Outdoors Day Activities at Six Corps Project Sites 2Health News:Rite Aid Health and Beauty Expo to Showcase GNC Athletes 2
(Date:9/18/2014)...  PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results ... June 30, 2014. Quarter Ended June ... 30, 2014 increased $492,000, or 18%, to $3.2 million ... 30, 2013, due primarily to an increase of $746,000 ... Company,s largest customer, partially offset by an aggregate decrease ...
(Date:9/18/2014)... Sept. 18, 2014  Casen Buswell has a rare vascular ... harden.  His case is one of only 14 known cases ... only hospital in the United States , ... treatment with the dual wave-length laser, is Methodist Children,s Hospital, ... . Using a laser available in South ...
(Date:9/18/2014)... LONDON , Sept. 18, 2014 ... for innovation, increasing clinical development costs, new technologies ... fast-changing environment are important factors driving industry change. ... trial costs continue to rise due to a ... conducted by industry think tanks suggest each day ...
Breaking Medicine Technology:Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 2Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 3Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 4Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 5Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 6Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 7Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 8Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 9Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 10Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 11Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 12Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 13Methodist Children's Hospital In San Antonio, TX Only Hospital In The U.S. Treating Rare Vascular Condition With Dual Wave-Length Laser 2Patient Recruitment in Asia Biotech and Pharma Companies 2Patient Recruitment in Asia Biotech and Pharma Companies 3
... Generex Biotechnology Corporation ( www.generex.com ) (OTC Bulletin ... peer-reviewed scientific journal Diabetes, Obesity and Metabolism ... Oral-lyn™, the Company,s proprietary buccal insulin spray product. ... subjects with impaired glucose tolerance: the prevoral study , ...
... Bionovo, Inc. (Nasdaq: BNVI ), a pharmaceutical company ... women,s health and cancer, today announced that it had received ... Clinical Guidance meeting that took place on November 8, 2010. ... overall clinical development plan. "We had a ...
Cached Medicine Technology:Generex Announces Publication of New Positive Generex Oral-lyn™ Data in Peer-Reviewed Journal 2Generex Announces Publication of New Positive Generex Oral-lyn™ Data in Peer-Reviewed Journal 3Generex Announces Publication of New Positive Generex Oral-lyn™ Data in Peer-Reviewed Journal 4Generex Announces Publication of New Positive Generex Oral-lyn™ Data in Peer-Reviewed Journal 5Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 2Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 3Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 4
... The Akbarnia PDR Instruments ... surgeons negotiate in and around ... and reconstruction procedures. The instruments ... construction, a variety of angled ...
... is a point-of-care system designed for the ... to as Platelet Rich Plasma - PRP) ... small sample of blood. The Symphony II ... which are found in the platelets. The ...
... the introduction of the Leica Dual Imaging Color ... latest available information technology. All important and necessary ... Leica M520 / M500 N optical platform on ... a huge amount of benefits: highest brightness, contrast ...
... Headlight mounted micro video camera has been ... in areas otherwise invisible to all but ... The system may be used for all ... crowding of the sterile area and enabling ...
Medicine Products: